Literature DB >> 21653254

Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers.

Shalini Makawita1, Chris Smith, Ihor Batruch, Yingye Zheng, Felix Rückert, Robert Grützmann, Christian Pilarsky, Steven Gallinger, Eleftherios P Diamandis.   

Abstract

Pancreatic cancer is one of the leading causes of cancer-related deaths, for which serological biomarkers are urgently needed. Most discovery-phase studies focus on the use of one biological source for analysis. The present study details the combined mining of pancreatic cancer-related cell line conditioned media and pancreatic juice for identification of putative diagnostic leads. Using strong cation exchange chromatography, followed by LC-MS/MS on an LTQ-Orbitrap mass spectrometer, we extensively characterized the proteomes of conditioned media from six pancreatic cancer cell lines (BxPc3, MIA-PaCa2, PANC1, CAPAN1, CFPAC1, and SU.86.86), the normal human pancreatic ductal epithelial cell line HPDE, and two pools of six pancreatic juice samples from ductal adenocarcinoma patients. All samples were analyzed in triplicate. Between 1261 and 2171 proteins were identified with two or more peptides in each of the cell lines, and an average of 521 proteins were identified in the pancreatic juice pools. In total, 3479 nonredundant proteins were identified with high confidence, of which ∼ 40% were extracellular or cell membrane-bound based on Genome Ontology classifications. Three strategies were employed for identification of candidate biomarkers: (1) examination of differential protein expression between the cancer and normal cell lines using label-free protein quantification, (2) integrative analysis, focusing on the overlap of proteins among the multiple biological fluids, and (3) tissue specificity analysis through mining of publically available databases. Preliminary verification of anterior gradient homolog 2, syncollin, olfactomedin-4, polymeric immunoglobulin receptor, and collagen alpha-1(VI) chain in plasma samples from pancreatic cancer patients and healthy controls using ELISA, showed a significant increase (p < 0.01) of these proteins in plasma from pancreatic cancer patients. The combination of these five proteins showed an improved area under the receiver operating characteristic curve to CA19.9 alone. Further validation of these proteins is warranted, as is the investigation of the remaining group of candidates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21653254      PMCID: PMC3205865          DOI: 10.1074/mcp.M111.008599

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  121 in total

Review 1.  The grand challenge to decipher the cancer proteome.

Authors:  Samir Hanash; Ayumu Taguchi
Journal:  Nat Rev Cancer       Date:  2010-09       Impact factor: 60.716

2.  Quantitative analysis of proteome coverage and recovery rates for upstream fractionation methods in proteomics.

Authors:  Yuan Fang; Dale P Robinson; Leonard J Foster
Journal:  J Proteome Res       Date:  2010-04-05       Impact factor: 4.466

3.  Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis.

Authors:  Ru Chen; Sheng Pan; Kelly Cooke; Kara White Moyes; Mary P Bronner; David R Goodlett; Ruedi Aebersold; Teresa A Brentnall
Journal:  Pancreas       Date:  2007-01       Impact factor: 3.327

Review 4.  Advances in pancreatic cancer detection.

Authors:  Cristiana Pistol Tanase; Monica Neagu; Radu Albulescu; Mihail Eugen Hinescu
Journal:  Adv Clin Chem       Date:  2010       Impact factor: 5.394

5.  Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Ajay V Maker; Nora Katabi; Mithat Gonen; Ronald P DeMatteo; Michael I D'Angelica; Yuman Fong; William R Jarnagin; Murray F Brennan; Peter J Allen
Journal:  Ann Surg Oncol       Date:  2010-08-18       Impact factor: 5.344

6.  Proteomic analyses of pancreatic cyst fluids.

Authors:  Eileen Ke; Bhavinkumar B Patel; Tiffany Liu; Xin-Ming Li; Oleh Haluszka; John P Hoffman; Hormoz Ehya; Nancy A Young; James C Watson; David S Weinberg; Minhhuyen T Nguyen; Steven J Cohen; Neal J Meropol; Samuel Litwin; Jeffrey L Tokar; Anthony T Yeung
Journal:  Pancreas       Date:  2009-03       Impact factor: 3.327

7.  Elevated serum ribonuclease in patients with pancreatic cancer.

Authors:  K K Reddi; J F Holland
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

8.  Comparative proteomic analysis of human pancreatic juice: methodological study.

Authors:  Lu Zhou; ZhaoHui Lu; AiMing Yang; RuiXue Deng; CanRong Mai; XinTing Sang; Klaas Nico Faber; XingHua Lu
Journal:  Proteomics       Date:  2007-04       Impact factor: 3.984

Review 9.  Mass spectrometry-based label-free quantitative proteomics.

Authors:  Wenhong Zhu; Jeffrey W Smith; Chun-Ming Huang
Journal:  J Biomed Biotechnol       Date:  2009-11-10

10.  TiGER: a database for tissue-specific gene expression and regulation.

Authors:  Xiong Liu; Xueping Yu; Donald J Zack; Heng Zhu; Jiang Qian
Journal:  BMC Bioinformatics       Date:  2008-06-09       Impact factor: 3.169

View more
  42 in total

1.  Quantitative analysis of energy metabolic pathways in MCF-7 breast cancer cells by selected reaction monitoring assay.

Authors:  Andrei P Drabovich; Maria P Pavlou; Apostolos Dimitromanolakis; Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2012-04-25       Impact factor: 5.911

2.  Inferring alterations in cell-to-cell communication in HER2+ breast cancer using secretome profiling of three cell models.

Authors:  David J Klinke; Yogesh M Kulkarni; Yueting Wu; Christina Byrne-Hoffman
Journal:  Biotechnol Bioeng       Date:  2014-04-18       Impact factor: 4.530

3.  Stable Isotope Labeling with Amino Acids (SILAC)-Based Proteomics of Primary Human Kidney Cells Reveals a Novel Link between Male Sex Hormones and Impaired Energy Metabolism in Diabetic Kidney Disease.

Authors:  Sergi Clotet; Maria Jose Soler; Marta Riera; Julio Pascual; Fei Fang; Joyce Zhou; Ihor Batruch; Stella K Vasiliou; Apostolos Dimitromanolakis; Clara Barrios; Eleftherios P Diamandis; James W Scholey; Ana Konvalinka
Journal:  Mol Cell Proteomics       Date:  2017-01-04       Impact factor: 5.911

Review 4.  Proteomics analysis of bodily fluids in pancreatic cancer.

Authors:  Sheng Pan; Teresa A Brentnall; Ru Chen
Journal:  Proteomics       Date:  2015-04-27       Impact factor: 3.984

Review 5.  Strategies for discovering novel pancreatic cancer biomarkers.

Authors:  Alison Chan; Eleftherios P Diamandis; Ivan M Blasutig
Journal:  J Proteomics       Date:  2012-09-28       Impact factor: 4.044

6.  Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer.

Authors:  Alison Chan; Ioannis Prassas; Apostolos Dimitromanolakis; Randall E Brand; Stefano Serra; Eleftherios P Diamandis; Ivan M Blasutig
Journal:  Clin Cancer Res       Date:  2014-09-19       Impact factor: 12.531

7.  Polymeric immunoglobulin receptor expression is predictive of poor prognosis in glioma patients.

Authors:  Huanjiang Niu; Kun Wang; Yirong Wang
Journal:  Int J Clin Exp Med       Date:  2014-08-15

8.  Laminin, gamma 2 (LAMC2): a promising new putative pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues.

Authors:  Hari Kosanam; Ioannis Prassas; Caitlin C Chrystoja; Ireena Soleas; Alison Chan; Apostolos Dimitromanolakis; Ivan M Blasutig; Felix Rückert; Robert Gruetzmann; Christian Pilarsky; Masato Maekawa; Randall Brand; Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2013-06-24       Impact factor: 5.911

9.  In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion.

Authors:  Rodrigo Barderas; Marta Mendes; Sofia Torres; Rubén A Bartolomé; María López-Lucendo; Roi Villar-Vázquez; Alberto Peláez-García; Eduardo Fuente; Félix Bonilla; J Ignacio Casal
Journal:  Mol Cell Proteomics       Date:  2013-02-26       Impact factor: 5.911

10.  Double deficiency of cathepsins B and L results in massive secretome alterations and suggests a degradative cathepsin-MMP axis.

Authors:  Stefan Tholen; Martin L Biniossek; Martina Gansz; Theresa D Ahrens; Manuel Schlimpert; Jayachandran N Kizhakkedathu; Thomas Reinheckel; Oliver Schilling
Journal:  Cell Mol Life Sci       Date:  2013-06-29       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.